Comparison of Glycemic Control Achieved With 2 Different Needles

Completed · Phase 4

Conditions studied: Diabetes, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Delivery Systems

In brief

This trial is conducted in the United States of America (USA). The aim of this trial is to investigate if a 31 gauge x 6 mm needle will provide comparable blood glucose control to the 29 gauge x 12.7 mm needle in obese subjects with diabetes.

Key facts

Study ID

NCT00572052

Run by

Novo Nordisk A/S

People needed

62

Starts

2002-12-01

Expected to finish

2003-10-01

Last updated by the study team

2017-01-19

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diabetes mellitus
• Current treatment with insulin or insulin analogues for the last 6 months
• BMI greater than or equal to 30.0 kg/m2
• Currently injecting in the thigh or abdomen
• HbA1c below 10%

You may not qualify if…

• Severe, uncontrolled hypertension
• Self-mixing insulin
• Unwillingness to monitor blood glucose
• Pregnancy, breast-feeding, intention to become pregnant, or inadequate contraceptive measures

Where it is running

• Novo Nordisk Investigational Site — Walnut Creek, California, United States
• Novo Nordisk Investigational Site — Berlin, New Jersey, United States
• Novo Nordisk Investigational Site — Lawrenceville, New Jersey, United States
• Novo Nordisk Investigational Site — Kettering, Ohio, United States
• Novo Nordisk Investigational Site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.